| Hans-Günter Meyer-Thompson | Hepatitiden
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.
Waziry R, Hajarizadeh B, Grebely J, Amin J, Law M, Danta M, George J, Dore GJ.
J Hepatol. 2017 Aug 9. pii: S0168-8278(17)32199-2. doi: 10.1016/j.jhep.2017.07.025.
Abstract